Monoamine transporters: Insights from molecular dynamics simulations

Monoamine transporters: Insights from molecular dynamics simulations

The human monoamine transporters facilitate the reuptake of the neurotransmitters serotonin, dopamine, and norepinephrine from the synaptic cleft. Imbalance in monoaminergic neurotransmission is linked to various diseases including major depression, attention deficit hyperactivity disorder, schizoph...

Full description

Bibliographic Details
Main Authors:	Julie eGrouleff, Lucy Kate Ladefoged, Heidi eKoldsø, Birgit eSchiøtt
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-10-01
Series:	Frontiers in Pharmacology
Subjects:	serotonin transporter molecular dynamics monoamine transporters dopamine transporter norepinephrine transporter
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00235/full

Similar Items

Insights to ligand binding to the monoamine transporters – from homology modeling to LeuBAT and dDAT
by: Heidi eKoldsø, et al.
Published: (2015-09-01)

Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
by: Ole Valente Mortensen, et al.
Published: (2015-09-01)

Handling of intracellular K+ determines voltage dependence of plasmalemmal monoamine transporter function
by: Shreyas Bhat, et al.
Published: (2021-06-01)

Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions
by: Malik Alwindi, et al.
Published: (2023-11-01)

Implications for Combination Therapy of Selective Monoamine Reuptake Inhibitors on Dopamine Transporters
by: Hyomin Ahn, et al.
Published: (2023-10-01)

What mechanisms are responsible for the reuptake of levodopa-derived dopamine in parkinsonian striatum?
by: Haruo Nishijima, et al.
Published: (2016-12-01)

Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice
by: Melodi A. Bowman, et al.
Published: (2020-10-01)

Monoamine Levels and Parkinson’s Disease Progression: Evidence From a High-Performance Liquid Chromatography Study
by: Patsorn Wichit, et al.
Published: (2021-07-01)

Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Molecular docking and biochemical validation of (-)-syringaresinol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside binding to an allosteric site in monoamine transporters
by: Hanhe Liu, et al.
Published: (2022-10-01)

Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation
by: Mariam B. Camacho, et al.
Published: (2017-12-01)

Unique Substrate Recognition and Sodium–Substrate Binding Stoichiometry in a Bacterial Serotonin Transporter, TuriSERT
by: Mu Li, et al.
Published: (2023-12-01)

Stereoselectivity in the Membrane Transport of Phenylethylamine Derivatives by Human Monoamine Transporters and Organic Cation Transporters 1, 2, and 3
by: Lukas Gebauer, et al.
Published: (2022-10-01)

Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia
by: Samantha Alvarez-Herrera, et al.
Published: (2024-01-01)

Early Rearing Conditions Affect Monoamine Metabolite Levels During Baseline and Periods of Social Separation Stress: A Non-human Primate Model (Macaca mulatta)
by: Elizabeth K. Wood, et al.
Published: (2021-04-01)

Serotonin uptake via plasma membrane monoamine transporter during myocardial ischemia‐reperfusion in the rat heart in vivo
by: Takashi Sonobe, et al.
Published: (2019-11-01)

PET technology for drug development in psychiatry
by: Ryosuke Arakawa, et al.
Published: (2020-06-01)

Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)
by: Bruno P. Guiard, et al.
Published: (2011-01-01)

Monoaminergic Modulation of Motor Cortex Function
by: Clément Vitrac, et al.
Published: (2017-10-01)

Associations of serotonin transporter gene promoter polymorphisms and monoamine oxidase A gene polymorphisms with oppositional defiant disorder in a Chinese Han population
by: Chang-Hong Wang, et al.
Published: (2018-08-01)

Relative Nutritional Deficiencies Associated with Centrally Acting Monoamines [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

Assessment of Paroxetine Molecular Interactions with Selected Monoamine and γ-Aminobutyric Acid Transporters
by: Magdalena Kowalska, et al.
Published: (2021-06-01)

Relative Nutritional Deficiencies Associated with Centrally Acting Monoamines [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion
by: Lisette Blanco-Lezcano, et al.
Published: (2018-02-01)

Serotonin Transporter mRNA Expression Is Reduced in the Peripheral Blood Mononuclear Cells of Subjects with Major Depression but Normal in Fibromyalgia
by: Gaël Villanueva-Charbonneau, et al.
Published: (2023-10-01)

Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones
by: Dino Luethi, et al.
Published: (2019-04-01)

Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent
by: Donglang Jiang, et al.
Published: (2019-01-01)

Zanthoxylum alatum abrogates lipopolysaccharide-induced depression-like behaviours in mice by modulating neuroinflammation and monoamine neurotransmitters in the hippocampus
by: Chandana Choudhury Barua, et al.
Published: (2018-01-01)

A Conserved Intramolecular Ion-Pair Plays a Critical but Divergent Role in Regulation of Dimerization and Transport Function among the Monoamine Transporters
by: Sixiang Chen, et al.
Published: (2024-04-01)

The Discrediting of the Monoamine Hypothesis [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

Decreased pallidal vesicular monoamine transporter type 2 availability in Parkinson's disease: The contribution of the nigropallidal pathway
by: Sang Soo Cho, et al.
Published: (2019-04-01)

Abnormal brain development of monoamine oxidase mutant zebrafish and impaired social interaction of heterozygous fish
by: Diego Baronio, et al.
Published: (2022-03-01)

Autoradiographic localization of [3H]-Nisoxetine binding sites in the CNS of male and female Japanese quail
by: Shannon E. Eaton, et al.
Published: (2021-09-01)

Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of In Vitro Methods to Assess the Potency of Drugs That Target Monoamine Transporters
by: Marija Ilic, et al.
Published: (2020-05-01)

Corrigendum: Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of In Vitro Methods to Assess the Potency of Drugs That Target Monoamine Transporters
by: Marija Ilic, et al.
Published: (2022-03-01)

New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties
by: Yu C, et al.
Published: (2020-08-01)

Overlap and Specificity in the Substrate Spectra of Human Monoamine Transporters and Organic Cation Transporters 1, 2, and 3
by: Lukas Gebauer, et al.
Published: (2021-11-01)

Antidepressant activity: contribution of brain microdialysis in knock-out mice to the understanding of BDNF/5-HT transporter/5-HT autoreceptor interactions
by: Alain M Gardier
Published: (2013-08-01)

Alteration to Dopaminergic Synapses Following Exposure to Perfluorooctane Sulfonate (PFOS), in Vitro and in Vivo
by: Rahul Patel, et al.
Published: (2016-08-01)

AXONAL SEGREGATION AND ROLE OF THE VESICULAR GLUTAMATE TRANSPORTER VGLUT3 IN SEROTONIN NEURONS
by: Aurore N Voisin, et al.
Published: (2016-04-01)